Bachem Holding AG - BHM

Bachem Holding AG, a technology-based biochemicals company, provides services to the pharmaceutical and biotechnology industries primarily in Europe and North America. It develops and manufactures peptide and organic molecules as active pharmaceutical ingredients (APIs), as well as biochemicals for research purposes. The company offers research products, which include catalog products comprising peptides, amino acid derivatives, and biochemicals for peptide research; custom synthesis services; sterile products under the Clinalfa brand; and glycosylated peptides. It also provides API products comprising generic APIs used in the fields of cancer, diabetes, obesity, fertility, and others; and peptides for new chemical entities. In addition, the company offers customer support services, such as formulation development, sterile tox-vials, compatibility studies, stress tests, post-release stability studies, and other services, as chemistry, manufacturing, and control documentation services for investigational medicinal product dossier and investigational new drugs. Bachem Holding AG was founded in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG is a subsidiary of Ingro Finanz AG.